APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exportin 1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Exportin 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026182 pages

Choose your research edition.

Industry ResearchExportin 1 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Exportin 1 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Exportin 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exportin 1 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Exportin 1 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Exportin 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Exportin 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Exportin 1 include Biogen Inc, CanBas Co Ltd, Karyopharm Therapeutics Inc, Oita University Institute of Advanced Medicine Inc, Wigen Biomedicine Technology (Shanghai) Co Ltd and Jiangsu Carephar Pharmaceutical Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Exportin 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exportin 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exportin 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Exportin 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Exportin 1 Segment by Company

Biogen Inc

CanBas Co Ltd

Karyopharm Therapeutics Inc

Oita University Institute of Advanced Medicine Inc

Wigen Biomedicine Technology (Shanghai) Co Ltd

Jiangsu Carephar Pharmaceutical Co Ltd

Exportin 1 Segment by Type

Chromosome Region Maintenance 1 Protein Homolog

XPO1

Exportin 1 Segment by Application

Oncology

Central Nervous System

Genetic Disorders

Immunology

Infectious Disease

Exportin 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exportin 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exportin 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exportin 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Exportin 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Exportin 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Exportin 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Exportin 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Exportin 1 Industry Trends Table 2. Exportin 1 Industry Drivers Table 3. Exportin 1 Industry Opportunities and Challenges Table 4. Exportin 1 Industry Restraints Table 5. Global Exportin 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Exportin 1 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Exportin 1 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Exportin 1 Sales Market Share by Manufacturers Table 9. Global Exportin 1 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Exportin 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Exportin 1 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Exportin 1 Manufacturers, Product Type & Application Table 13. Global Exportin 1 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Exportin 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Chromosome Region Maintenance 1 Protein Homolog Table 17. Major Manufacturers of XPO1 Table 18. Global Exportin 1 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Exportin 1 Sales by Type (2021-2026) & (K Units) Table 20. Global Exportin 1 Sales by Type (2027-2032) & (K Units) Table 21. Global Exportin 1 Sales Market Share by Type (2021-2026) Table 22. Global Exportin 1 Sales Market Share by Type (2027-2032) Table 23. Global Exportin 1 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Exportin 1 Revenue by Type (2021-2026) & (K Units) Table 25. Global Exportin 1 Revenue by Type (2027-2032) & (K Units) Table 26. Global Exportin 1 Revenue Market Share by Type (2021-2026) Table 27. Global Exportin 1 Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Oncology Table 29. Major Manufacturers of Central Nervous System Table 30. Major Manufacturers of Genetic Disorders Table 31. Major Manufacturers of Immunology Table 32. Major Manufacturers of Infectious Disease Table 33. Global Exportin 1 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Exportin 1 Sales by Application (2021-2026) & (K Units) Table 35. Global Exportin 1 Sales by Application (2027-2032) & (K Units) Table 36. Global Exportin 1 Sales Market Share by Application (2021-2026) Table 37. Global Exportin 1 Sales Market Share by Application (2027-2032) Table 38. Global Exportin 1 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Exportin 1 Revenue by Application (2021-2026) & (K Units) Table 40. Global Exportin 1 Revenue by Application (2027-2032) & (K Units) Table 41. Global Exportin 1 Revenue Market Share by Application (2021-2026) Table 42. Global Exportin 1 Revenue Market Share by Application (2027-2032) Table 43. Global Exportin 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Exportin 1 Sales by Region (2021-2026) & (K Units) Table 45. Global Exportin 1 Sales Market Share by Region (2021-2026) Table 46. Global Exportin 1 Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Exportin 1 Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Exportin 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Exportin 1 Sales by Country (2021-2026) & (K Units) Table 50. North America Exportin 1 Sales by Country (2027-2032) & (K Units) Table 51. Europe Exportin 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Exportin 1 Sales by Country (2021-2026) & (K Units) Table 53. Europe Exportin 1 Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Exportin 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Exportin 1 Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Exportin 1 Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Exportin 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Exportin 1 Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Exportin 1 Sales by Country (2027-2032) & (K Units) Table 60. Global Exportin 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Exportin 1 Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Exportin 1 Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Exportin 1 Revenue Market Share by Region (2021-2026) Table 64. Global Exportin 1 Revenue Market Share by Region (2027-2032) Table 65. Biogen Inc Company Information Table 66. Biogen Inc Business Overview Table 67. Biogen Inc Exportin 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Biogen Inc Exportin 1 Product Portfolio Table 69. Biogen Inc Recent Development Table 70. CanBas Co Ltd Company Information Table 71. CanBas Co Ltd Business Overview Table 72. CanBas Co Ltd Exportin 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. CanBas Co Ltd Exportin 1 Product Portfolio Table 74. CanBas Co Ltd Recent Development Table 75. Karyopharm Therapeutics Inc Company Information Table 76. Karyopharm Therapeutics Inc Business Overview Table 77. Karyopharm Therapeutics Inc Exportin 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Karyopharm Therapeutics Inc Exportin 1 Product Portfolio Table 79. Karyopharm Therapeutics Inc Recent Development Table 80. Oita University Institute of Advanced Medicine Inc Company Information Table 81. Oita University Institute of Advanced Medicine Inc Business Overview Table 82. Oita University Institute of Advanced Medicine Inc Exportin 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Oita University Institute of Advanced Medicine Inc Exportin 1 Product Portfolio Table 84. Oita University Institute of Advanced Medicine Inc Recent Development Table 85. Wigen Biomedicine Technology (Shanghai) Co Ltd Company Information Table 86. Wigen Biomedicine Technology (Shanghai) Co Ltd Business Overview Table 87. Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product Portfolio Table 89. Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Development Table 90. Jiangsu Carephar Pharmaceutical Co Ltd Company Information Table 91. Jiangsu Carephar Pharmaceutical Co Ltd Business Overview Table 92. Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product Portfolio Table 94. Jiangsu Carephar Pharmaceutical Co Ltd Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Exportin 1 Distributors List Table 98. Exportin 1 Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Exportin 1 Product Image Figure 2. Global Exportin 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exportin 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Exportin 1 Sales (2021-2032) & (K Units) Figure 5. Global Exportin 1 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Exportin 1 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Chromosome Region Maintenance 1 Protein Homolog Image Figure 9. XPO1 Image Figure 10. Global Exportin 1 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Exportin 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Exportin 1 Sales Market Share by Type (2021-2032) Figure 13. Global Exportin 1 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Exportin 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Exportin 1 Revenue Market Share by Type (2021-2032) Figure 16. Oncology Image Figure 17. Central Nervous System Image Figure 18. Genetic Disorders Image Figure 19. Immunology Image Figure 20. Infectious Disease Image Figure 21. Global Exportin 1 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Exportin 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Exportin 1 Sales Market Share by Application (2021-2032) Figure 24. Global Exportin 1 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Exportin 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Exportin 1 Revenue Market Share by Application (2021-2032) Figure 27. North America Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Exportin 1 Sales Market Share by Country (2021-2032) Figure 29. U.S. Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Exportin 1 Sales Market Share by Country (2021-2032) Figure 34. Germany Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Exportin 1 Sales Market Share by Country (2021-2032) Figure 41. China Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Exportin 1 Sales Market Share by Country (2021-2032) Figure 49. Brazil Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Exportin 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Exportin 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Exportin 1 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Exportin 1 Revenue (2021-2032) & (US$ Million) Figure 60. North America Exportin 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Exportin 1 Revenue (2021-2032) & (US$ Million) Figure 62. Europe Exportin 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Exportin 1 Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Exportin 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Exportin 1 Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Exportin 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Exportin 1 Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Exportin 1 Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Chromosome Region Maintenance 1 Protein Homolog
  • XPO1
Applications
  • Oncology
  • Central Nervous System
  • Genetic Disorders
  • Immunology
  • Infectious Disease
Companies covered
  • Biogen Inc
  • CanBas Co Ltd
  • Karyopharm Therapeutics Inc
  • Oita University Institute of Advanced Medicine Inc
  • Wigen Biomedicine Technology (Shanghai) Co Ltd
  • Jiangsu Carephar Pharmaceutical Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Exportin 1 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Exportin 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Exportin 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Exportin 1 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Exportin 1 Market Dynamics
  1. 2.1 Exportin 1 Industry Trends
  2. 2.2 Exportin 1 Industry Drivers
  3. 2.3 Exportin 1 Industry Opportunities and Challenges
  4. 2.4 Exportin 1 Industry Restraints
3 Exportin 1 Market by Manufacturers
  1. 3.1 Global Exportin 1 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Exportin 1 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Exportin 1 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Exportin 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Exportin 1 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Exportin 1 Manufacturers, Product Type & Application
  7. 3.7 Global Exportin 1 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Exportin 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Exportin 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Exportin 1 Tier 1, Tier 2, and Tier 3
4 Exportin 1 Market by Type
  1. 4.1 Exportin 1 Type Introduction
  2. 4.1.1 Chromosome Region Maintenance 1 Protein Homolog
  3. 4.1.2 XPO1
  4. 4.2 Global Exportin 1 Sales by Type
  5. 4.2.1 Global Exportin 1 Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Exportin 1 Sales by Type (2021-2032)
  7. 4.2.3 Global Exportin 1 Sales Market Share by Type (2021-2032)
  8. 4.3 Global Exportin 1 Revenue by Type
  9. 4.3.1 Global Exportin 1 Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Exportin 1 Revenue by Type (2021-2032)
  11. 4.3.3 Global Exportin 1 Revenue Market Share by Type (2021-2032)
5 Exportin 1 Market by Application
  1. 5.1 Exportin 1 Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Central Nervous System
  4. 5.1.3 Genetic Disorders
  5. 5.1.4 Immunology
  6. 5.1.5 Infectious Disease
  7. 5.2 Global Exportin 1 Sales by Application
  8. 5.2.1 Global Exportin 1 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Exportin 1 Sales by Application (2021-2032)
  10. 5.2.3 Global Exportin 1 Sales Market Share by Application (2021-2032)
  11. 5.3 Global Exportin 1 Revenue by Application
  12. 5.3.1 Global Exportin 1 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Exportin 1 Revenue by Application (2021-2032)
  14. 5.3.3 Global Exportin 1 Revenue Market Share by Application (2021-2032)
6 Global Exportin 1 Sales by Region
  1. 6.1 Global Exportin 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exportin 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Exportin 1 Sales by Region (2021-2026)
  4. 6.2.2 Global Exportin 1 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Exportin 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Exportin 1 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Exportin 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Exportin 1 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Exportin 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Exportin 1 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Exportin 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Exportin 1 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Exportin 1 Revenue by Region
  1. 7.1 Global Exportin 1 Revenue by Region
  2. 7.1.1 Global Exportin 1 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Exportin 1 Revenue by Region (2021-2026)
  4. 7.1.3 Global Exportin 1 Revenue by Region (2027-2032)
  5. 7.1.4 Global Exportin 1 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Exportin 1 Revenue (2021-2032)
  8. 7.2.2 North America Exportin 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Exportin 1 Revenue (2021-2032)
  11. 7.3.2 Europe Exportin 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Exportin 1 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Exportin 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Exportin 1 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Exportin 1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Biogen Inc
  2. 8.1.1 Biogen Inc Company Information
  3. 8.1.2 Biogen Inc Business Overview
  4. 8.1.3 Biogen Inc Exportin 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biogen Inc Exportin 1 Product Portfolio
  6. 8.1.5 Biogen Inc Recent Developments
  7. 8.2 CanBas Co Ltd
  8. 8.2.1 CanBas Co Ltd Company Information
  9. 8.2.2 CanBas Co Ltd Business Overview
  10. 8.2.3 CanBas Co Ltd Exportin 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CanBas Co Ltd Exportin 1 Product Portfolio
  12. 8.2.5 CanBas Co Ltd Recent Developments
  13. 8.3 Karyopharm Therapeutics Inc
  14. 8.3.1 Karyopharm Therapeutics Inc Company Information
  15. 8.3.2 Karyopharm Therapeutics Inc Business Overview
  16. 8.3.3 Karyopharm Therapeutics Inc Exportin 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Karyopharm Therapeutics Inc Exportin 1 Product Portfolio
  18. 8.3.5 Karyopharm Therapeutics Inc Recent Developments
  19. 8.4 Oita University Institute of Advanced Medicine Inc
  20. 8.4.1 Oita University Institute of Advanced Medicine Inc Company Information
  21. 8.4.2 Oita University Institute of Advanced Medicine Inc Business Overview
  22. 8.4.3 Oita University Institute of Advanced Medicine Inc Exportin 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Oita University Institute of Advanced Medicine Inc Exportin 1 Product Portfolio
  24. 8.4.5 Oita University Institute of Advanced Medicine Inc Recent Developments
  25. 8.5 Wigen Biomedicine Technology (Shanghai) Co Ltd
  26. 8.5.1 Wigen Biomedicine Technology (Shanghai) Co Ltd Company Information
  27. 8.5.2 Wigen Biomedicine Technology (Shanghai) Co Ltd Business Overview
  28. 8.5.3 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wigen Biomedicine Technology (Shanghai) Co Ltd Exportin 1 Product Portfolio
  30. 8.5.5 Wigen Biomedicine Technology (Shanghai) Co Ltd Recent Developments
  31. 8.6 Jiangsu Carephar Pharmaceutical Co Ltd
  32. 8.6.1 Jiangsu Carephar Pharmaceutical Co Ltd Company Information
  33. 8.6.2 Jiangsu Carephar Pharmaceutical Co Ltd Business Overview
  34. 8.6.3 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Carephar Pharmaceutical Co Ltd Exportin 1 Product Portfolio
  36. 8.6.5 Jiangsu Carephar Pharmaceutical Co Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Exportin 1 Value Chain Analysis
  2. 9.1.1 Exportin 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Exportin 1 Production Mode & Process
  6. 9.2 Exportin 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Exportin 1 Distributors
  9. 9.2.3 Exportin 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst